Log inSign up

Biohaven Pharmaceuticals

5 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

Warren Volles
General Counsel & Chief Legal Officer
George Clark
VP, Chief Accounting Officer
Robert Croop
Chief Development Officer, Neurology
Bruce D. Car
Chief Scientific Officer
Tova Gardin
Chief Translational Officer
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Matthew Buten
Chief Financial Officer
Elyse Stock
Senior Scientific Advisor
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
David Stock
VP, Biostatistics
Michael Bozik
President, Ion Channel Research & Development
Melissa Beiner
Director, R&D
Wes Kazmierski
Senior Director, Chemistry
Katy Mcgrath
Principal Scientist, In Vivo Science
David Weaver
SVP, Neuroscience & Pharmacology

Teams

+40

Leadership Team

43 members

+36

Clinical Operations Team

39 members

+26

Research and Development Team

29 members

+4

Legal and Compliance Team

7 members

Similar companies

GRAIL

27 followers

Exelixis

11 followers

NeoGenomics

8 followers

Legend Biotech

5 followers

Illumina

67 followers

Verily Life Sciences

36 followers

BioMarin Pharmaceutical

34 followers

Natera

13 followers

Cytokinetics

11 followers

Ultragenyx Pharmaceutical

10 followers

UNITY Biotechnology

12 followers

Explore companies